Background and Study Aims: There is no consensus as to what endoscopic hemostatic therapy and pharmacotherapy should be used in peptic ulcer hemorrhage (PUH). We conducted a mail survey to investigate current management of ulcer hemorrhage in the Netherlands.
Methods: A questionnaire was sent to gastroenterologists or, if not present, to internists, performing endoscopies, in every hospital in the Netherlands (n = 123). Endoscopic hemostatic therapy, pharmacotherapy, endoscopic reintervention, and management of Helicobacter pylori were evaluated.
Results: 90/123 (73 %) questionnaires were returned. Endoscopic hemostatic therapy is given in ulcers classified as Forrest Ia, Ib, IIa, IIb, and IIc by, respectively, 89 %, 93 %, 83 %, 47 %, and 19 % of respondents. Gastroenterologists perform endoscopic therapy more often in Forrest Ib (P = 0.03), IIa (P = 0.002), and IIb (P = 0.001) ulcers when compared with internists. Endoscopic injection therapy is used by 93 % of respondents as first modality. Epinephrine combined with polidocanol is most commonly used (60 %). Pharmacotherapy is given by 97 %. A total of 71 % use proton pump inhibitors (PPIs), and 26 % use H2-receptor antagonists (H2RAs), both mainly initially given intravenously. In case of suspected rebleeding, endoscopic reintervention is performed by 76 %, including a significantly greater percentage of gastroenterologists (89 % of gastroenterologists vs. 60 % of internists, P = 0.005), whereas the others refer the patient directly for surgery. Almost all respondents investigate for H. pylori. Eradication is confirmed by only 64 % (80 % of gastroenterologists vs. 50 % of internists, P = 0.004).
Conclusions: There are important differences in management of peptic ulcer hemorrhage between gastroenterologists and internists in the Netherlands. Management is only partly in accordance with evidence-based medicine.
References
-
1
Vreeburg E M, Snel P, de Bruijne J W, et al.
Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome.
Am J Gastroenterol.
1997;
92
236-243
-
2
Hui W M, Ng M M, Lok A S, et al.
A randomized comparative study of laser photocoagulation, heater probe, and bipolar electrocoagulation in the treatment of actively bleeding ulcers.
Gastrointest Endosc.
1991;
37
299-304
-
3
Laine L, Peterson W L.
Bleeding peptic ulcer.
N Engl J Med.
1994;
331
717-727
-
4
Jaramillo J L, Galvez C, Carmona C, et al.
Prediction of further hemorrhage in bleeding peptic ulcer.
Am J Gastroenterol.
1994;
89
2135-2138
-
5
Rockall T A, Logan R F, Devlin H B, et al.
Risk assessment after acute upper gastrointestinal haemorrhage.
Gut.
1996;
38
316-321
-
6
Brullet E, Campo R, Calvet X, et al.
Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer.
Gut.
1996;
39
155-158
-
7
Skok P.
How efficient is endoscopic injection sclerotherapy in peptic ulcer hemorrhage.
Hepatogastroenterology.
1997;
44
861-865
-
8
Villanueva C, Balanzo J.
A practical guide to the management of bleeding ulcers.
Drugs.
1997;
53
389-403
-
9
Kubba A K, Palmer K R.
Role of endoscopic injection therapy in the treatment of bleeding peptic ulcer.
Br J Surg.
1996;
83
461-468
-
10
Cook D J, Guyatt G H, Salena B J, et al.
Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis.
Gastroenterology.
1992;
102
139-148
-
11
NIH Consensus C onference.
Therapeutic endoscopy and bleeding ulcers.
JAMA.
1989;
262
1369-1372
-
12
ASGE Standards of Practice C ommittee.
The role of endoscopy in the management of non-variceal acute upper gastrointestinal bleedings. Guidelines for clinical application.
Gastrointest Endosc.
1992;
38
760-764
-
13
Lin H J, Lo W C, Lee F Y, et al.
A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.
Arch Intern Med.
1998;
158
54-58
-
14
Hasselgren G, Lind T, Lundell L, et al.
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study.
Scand J Gastroenterol.
1997;
32
328-333
-
15
Schaffalitzky de Muckadell O B, Havelund T, Harling H, et al.
Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study.
Scand J Gastroenterol.
1997;
32
320-327
-
16
Daneshmend T K, Hawkey C J, Langman M J, et al.
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.
BMJ.
1992;
304
143-147
-
17
Forrest J A, Finlayson N D, Shearman D J.
Endoscopy in gastrointestinal bleeding.
Lancet.
1974;
2
394-397
-
18
Cooper G S, Chak A, Way L E, et al.
Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery, and length of hospital stay.
Gastrointest Endosc.
1999;
49
145-152
-
19
Saeed Z A, Ramirez F C, Hepps K S, et al.
Prospective validation of the Baylor bleeding score for predicting the likelihood of rebleeding after endoscopic hemostasis of peptic ulcers.
Gastrointest Endosc.
1995;
41
561-565
-
20
Vreeburg E M, Terwee C B, Snel P, et al.
Validation of the Rockall risk scoring system in upper gastrointestinal bleeding.
Gut.
1999;
44
331-335
-
21
Laine L, Freeman M, Cohen H.
Lack of uniformity in evaluation of endoscopic prognostic features of bleeding ulcers.
Gastrointest Endosc.
1994;
4
411-417
-
22
Freeman M L, Cass O W, Peine C J, et al.
The non-bleeding visible vessel versus the sentinel clot: natural history and risk of rebleeding.
Gastrointest Endosc.
1993;
39
359-366
-
23
Mondardini A, Barletti C, Rocca G, et al.
Non-variceal upper gastrointestinal bleeding and Forrest's classification: diagnostic agreement between endoscopists from the same area.
Endoscopy.
1998;
3
508-512
-
24
Lau J Y, Leung J W.
Injection therapy for bleeding peptic ulcers.
Gastrointest Endosc Clin N Am.
1997;
7
575-591
-
25
Beckly D E, Casebow M P.
Prediction of rebleeding from peptic ulcer experience with an endoscopic Doppler device.
Gut.
1986;
27
96-99
-
26
Kohler B, Maier M, Benz C, et al.
Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy.
Dig Dis Sci.
1997;
42
1370-1374
-
27
Kohler B, Riemann J F.
Endoscopic injection therapy of Forrest II and III gastroduodenal ulcers guided by endoscopic Doppler ultrasound.
Endoscopy.
1993;
25
219-223
-
28
Fullarton G M, Murray W R.
Prediction of rebleeding in peptic ulcers by visual stigmata and endoscopic Doppler ultrasound criteria.
Endoscopy.
1990;
22
68-71
-
29
Wong R CK, Chak A, Kobayashi K, et al.
Role of doppler ultrasound in acute peptic ulcer hemorrhage: can it predict failure of endoscopic treatment [abstract]?.
Gastrointest Endosc.
1999;
49
AB 170
-
30
Grosso C, Rossi A, Gambitta P, et al.
Non-bleeding visible vessel treatment: perendoscopic injection therapy versus omeprazole infusion.
Scand J Gastroenterol.
1995;
3
872-875
-
31
Bleau B L, Gostout C J, Shaw M J, et al.
Final results: rebleeding from peptic ulcers associated with adherent clots: a prospective randomized controlled study comparing endoscopic therapy with medical therapy [abstract].
Gastrointest Endosc.
1997;
45
AB 87
-
32
Mallery S, Freeman M L, Cass O W, et al.
Rebleeding from gastroduodenal peptic ulcers in the age of endoscopic therapy [abstract].
Gastrointest Endosc.
1996;
43
353
-
33
Chung S C, Leung J W, Steele R J, et al.
Endoscopic injection of adrenaline for actively bleeding ulcers: a randomised trial.
Br Med J.
1988;
296
1631-1633
-
34
Lin H J, Perng C L, Lee F Y, et al.
Endoscopic injection for the arrest of peptic ulcer hemorrhage: final results of a prospective, randomized comparative trial.
Gastrointest Endosc.
1993;
39
15-19
-
35
Pulanic R, Vucelic B, Rosandic M, et al.
Comparison of injection sclerotherapy and laser photocoagulation for bleeding peptic ulcers.
Endoscopy.
1995;
27
291-297
-
36
Llach J, Bordas J M, Salmeron J M, et al.
A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage.
Gastrointest Endosc.
1996;
43
117-120
-
37
Chung S S, Lau J Y, Sung J J, et al.
Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers.
BMJ.
1997;
314
1307-1311
-
38
Chung S C, Leung J W, Sung J Y, et al.
Injection or heat probe for bleeding ulcer.
Gastroenterology.
1991;
1
33-37
-
39
Villanueva C, Balanzo J, Espinos J C, et al.
Endoscopic injection therapy of bleeding ulcer: a prospective and randomized comparison of adrenaline alone or with polidocanol.
J Clin Gastroenterol.
1993;
17
195-200
-
40
Chung S C, Leung J W, Leong H T, et al.
Adding a sclerosant to endoscopic epinephrine injection in actively bleeding ulcers: a randomized trial.
Gastrointest Endosc.
1993;
39
611-615
-
41
Lin H J, Perng C L, Lee S D.
Is sclerosant injection mandatory after an epinephrine injection for arrest of peptic ulcer haemorrhage. A prospective, randomised, comparative study.
Gut.
1993;
34
1182-1185
-
42
Choudari C P, Palmer K R.
Endoscopic injection therapy for bleeding peptic ulcer; a comparison of adrenaline alone with adrenaline plus ethanolamine oleate.
Gut.
1994;
35
608-610
-
43
Chung S C, Leong H T, Chan A C, et al.
Epinephrine or epinephrine plus alcohol for injection of bleeding ulcers: a prospective randomized trial.
Gastrointest Endosc.
1996;
43
591-595
-
44
Kubba A K, Lessells A, Palmer K R.
Experimental studies of injection therapy for ulcer haemorrhage in rabbits.
Br J Surg.
1997;
84
551-554
-
45
Rutgeerts P, Geboes K, Vantrappen G.
Experimental studies of injection therapy for severe nonvariceal bleeding in dogs.
Gastroenterology.
1989;
97
610-621
-
46
Loperfido S, Patelli G, La Torre L.
Extensive necrosis of gastric mucosa following injection therapy of bleeding peptic ulcer.
Endoscopy.
1990;
22
285-286
-
47
Lee J G, Lieberman D A.
Complications related to endoscopic hemostasis techniques.
Gastrointest Endosc Clin N Am.
1996;
6
305-321
-
48
Rutgeerts P, Rauws E, Wara P, et al.
Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer.
Lancet.
1997;
35
692-696
-
49
Kubba A K, Murphy W, Palmer K R.
Endoscopic injection for bleeding peptic ulcer: a comparison of adrenaline alone with adrenaline plus human thrombin.
Gastroenterology.
1996;
111
623-628
-
50
Lin H J, Tseng G Y, Perng C L, et al.
Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding.
Gut.
1999;
44
715-719
-
51
Jensen D M, Smith J, Savides T J, et al.
Randomized controlled study of combination epinephrine injection and gold probe compared to gold probe alone for hemostasis of actively bleeding peptic ulcers [abstract].
Gastrointest Endosc.
2000;
51
AB 130
-
52
Jensen D M, Kovacs T O, Jutabha R, et al.
Randomized, prospective study of bipolar coagulation alone compared to combination epinephrine injection and bipolar coagulation for prevention of rebleeding from ulcers with non-bleeding visible vessels [abstract].
Gastrointest Endosc.
2000;
51
AB 130
-
53
Rutgeerts P, Vantrappen G, Broeckaert L, et al.
Comparison of endoscopic polidocanol injection and YAG laser therapy for bleeding peptic ulcers.
Lancet.
1989;
1
1164-1167
-
54
Green F W, Jr., Kaplan M M, Curtis L E, et al.
Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage.
Gastroenterology.
1978;
74
38-43
-
55
Patchett S E, Enright H, Afdhal N, et al.
Clot lysis by gastric juice: an in vitro study.
Gut.
1989;
3
1704-1707
-
56
Kiilerich S, Rannem T, Elsborg L.
Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
Digestion.
1995;
56
25-30
-
57
Teyssen S, Chari S T, Scheid J, et al.
Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects.
Dig Dis Sci.
1995;
4
247-255
-
58
Reynolds J R, Walt R P, Clark A G, et al.
Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine.
Aliment Pharmacol Ther.
1987;
1
23-30
-
59
Brunner G, Luna P, Hartmann M, et al.
Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.
Yale J Biol Med.
1996;
69
225-231
-
60
Netzer P, Gaia C, Sandoz M, et al.
Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Am J Gastroenterol.
1999;
94
351-357
-
61
Brunner G, Chang J.
Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial.
Digestion.
1990;
45
217-225
-
62
Coraggio F, Rotondano G, Marmo R, et al.
Somatostatin in the prevention of recurrent bleeding after endoscopic haemostasis of peptic ulcer haemorrhage: a preliminary report.
Eur J Gastroenterol Hepatol.
1998;
1
673-676
-
63
Khuroo M S, Yattoo G N, Javid G, et al.
A comparison of omeprazole and placebo for bleeding peptic ulcer.
N Engl J Med.
1997;
336
1054-1058
-
64
Saeed Z A, Cole R A, Ramirez F C, et al.
Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: a prospective randomized trial.
Endoscopy.
1996;
28
288-294
-
65
Lin C K, Lai K H, Lo G H, et al.
The value of second-look endoscopy after endoscopic injection therapy for bleeding peptic ulcer [abstract].
Gastroenterology.
1996;
11
AB177
-
66
Messmann H, Schaller P, Andus T, et al.
Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.
Endoscopy.
1998;
3
583-589
-
67
Villanueva C, Balanzo J, Torras X, et al.
Value of second-look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial.
Gastrointest Endosc.
1994;
4
34-39
-
68
Lau J Y, Sung J J, Lam Y H, et al.
Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers.
N Engl J Med.
1999;
34
751-756
-
69
European Helicobacter Pylori Study G roup.
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report.
Gut.
1997;
41
8-13
M. E. van Leerdam,M.D.
Dept. of Gastroenterology
Academic Medical Center
Meibergdreef 9 1105 AZ
Amsterdam The Netherlands
Fax: Fax:+ 31-20-6917033
Email: E-mail:m. e.vanleerdam@amc.uva.nl
